MCRB LOSS ALERT Rosen Law Firm Reminds Seres Therapeutics, Inc. Investors of Important November 28 Deadline in Lawsuit - MCRB
November 23 2016 - 10:01AM
Business Wire
Rosen Law Firm, a global investor rights law firm, reminds
purchasers of Seres Therapeutics, Inc. securities (NASDAQ:MCRB)
from June 25, 2015 through July 29, 2016, both dates inclusive (the
“Class Period”) of the important November 28, 2016 lead plaintiff
deadline in the class action. The lawsuit seeks to recover damages
for Seres Therapeutics investors under the federal securities
laws.
To join the Seres Therapeutics class action, go to the firm’s
website at http://rosenlegal.com/cases-961.html or call Phillip
Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for more information on
the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
issued false and misleading statements to investors that Seres
Therapeutics advertised and hyped its lead drug product candidate
SER-109 as “novel class of biological drugs” and a potential
“first-in-field drug” despite knowledge that the Phase 2 clinical
trial of SER-109 would fail to achieve its primary endpoint as
compared to placebo. When the true details entered the market, the
lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
November 28, 2016. A lead plaintiff is a representative party
acting on behalf of other class members in directing the
litigation. If you wish to join the litigation, go to the firm’s
website at http://rosenlegal.com/cases-961.html for more
information. You may also contact Phillip Kim, Esq. or Kevin Chan,
Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at
pkim@rosenlegal.com or kchan@rosenlegal.com. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
-------------------------------
Contact Information:Laurence Rosen, Esq.Phillip Kim, Esq.Kevin
Chan, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 34th FloorNew
York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax:
(212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161123005419/en/
The Rosen Law Firm, P.A.866-767-3653Phillip Kim,
Esq.pkim@rosenlegal.comorKevin Chan, Esq.kchan@rosenlegal.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2023 to Apr 2024